Cargando…

Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs

Detalles Bibliográficos
Autores principales:	Yu, Bo, Li, Chenze, Chen, Peng, Li, Jia, Jiang, Hualiang, Wang, Dao-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science China Press 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406960/ https://www.ncbi.nlm.nih.gov/pubmed/32761451 http://dx.doi.org/10.1007/s11427-020-1782-1

Ejemplares similares

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

Can we use hydroxychloroquine to treat COVID-19 now?
por: Chen, Jun, et al.
Publicado: (2021)

First evaluation of hydroxychloroquine recommendations in treating SARS-CoV-2
por: Roussel, Y., et al.
Publicado: (2020)

Comment on: Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Pareek, Anil, et al.
Publicado: (2019)

Comment on: incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine: reply
por: Singh, Dilpreet K, et al.
Publicado: (2019)

Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis
por: Zeppieri, Marco
Publicado: (2023)

Is hydroxychloroquine beneficial for COVID-19 patients?
por: Li, Xing, et al.
Publicado: (2020)

Fixed Drug Eruption to Hydroxychloroquine
por: Swarnkar, Bhavya, et al.
Publicado: (2021)

Update on hydroxychloroquine use in pregnancy
por: Nori, Wassan, et al.
Publicado: (2023)

A Ringed Enigma: A Case of Annular Elastolytic Giant Cell Granuloma Successfully Treated with Hydroxychloroquine
por: Kansara, Kajal G., et al.
Publicado: (2023)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura
por: Arıkan, Fatma, et al.
Publicado: (2020)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Hydroxychloroquine: is there a role in long COVID?
por: Wang, Samuel S. Y., et al.
Publicado: (2023)

Hydroxychloroquine for the management of chronic chikungunya arthritis
por: Nogueira, Igor Albuquerque, et al.
Publicado: (2023)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Hydroxychloroquine (HCQ): real treatment or false hope?
por: El Bakkouri, Karim
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Letter to the editor: The effect of hydroxychloroquine on COVID-19
por: Demir, Canan, et al.
Publicado: (2022)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023)

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine
por: Verheijen, S., et al.
Publicado: (2021)

Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
por: Sun, Xiaoxuan, et al.
Publicado: (2020)

Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients
por: Rani, Seema, et al.
Publicado: (2020)

The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: Mo, De-Gang, et al.
Publicado: (2022)

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
por: Li, Qiuyu, et al.
Publicado: (2021)

Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b
por: Hong, Sun In, et al.
Publicado: (2020)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020)

Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
por: Carbillon, Lionel, et al.
Publicado: (2021)

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
por: Emmanuel, Stip, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
por: Simova, I., et al.
Publicado: (2020)

COVID-19 and hydroxychloroquine: Let the available data speak for themselves
por: Paliani, Ugo, et al.
Publicado: (2020)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

A case of Melkersson–Rosenthal syndrome successfully treated with hydroxychloroquine
por: Caccavale, Stefano, et al.
Publicado: (2022)

Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend
por: Hor, Chee Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ompgprjbfciobu3cas3bqt2ua9